Walter M. Stadler to Oligodeoxyribonucleotides
This is a "connection" page, showing publications Walter M. Stadler has written about Oligodeoxyribonucleotides.
Connection Strength
0.088
-
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):689-94.
Score: 0.072
-
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors. Ann Oncol. 2005 Jun; 16(6):958-65.
Score: 0.016